Peter leaves for India this week for business development activities with prospective regional pharma partners. Ultimately, he will endeavor to determine which entity or entities are appropriate to enter into an MOU regarding PV-10. It would/could be reasonable to expect he'll meet with Ranbaxy Laboratories (majority owned by Daiichi Sankyo), Sun Pharmaceutical Industries (because folks visited the blog from offices in Mumbai's Acme Plaza) and Pfizer India (well, you know my thoughts about Pfizer...), among others.
Sun Pharma is India's largest pharmaceutical company by market capitalization. A Sun Pharma PR last week noted Sun Pharmaceuticals recent market cap was greater than Dr Reddy’s Laboratories, Cipla and Lupin's combined capitalizations.